Overview, Update, and Lessons Learned From the International EQ-5D-5L Valuation Work: Version 2 of the EQ-5D-5L Valuation Protocol

被引:220
|
作者
Stolk, Elly [1 ]
Ludwig, Kristina [1 ,2 ]
Rand, Kim [3 ,4 ]
van Hout, Ben [5 ]
Ramos-Goni, Juan Manuel [1 ]
机构
[1] EuroQol Res Fdn, Marten Meesweg 107, NL-3068 AV Rotterdam, Netherlands
[2] Bielefeld Univ, Hlth Econ & Hlth Care Management, Bielefeld, Germany
[3] Univ Oslo, Dept Hlth Management & Hlth Econ, Oslo, Norway
[4] Akershus Univ Hosp, Hlth Serv Res Ctr, Lorenskog, Norway
[5] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England
关键词
discrete choice experiment; EQ-5D-5L; health valuation; time trade-off; utilities; VALUE SET; HEALTH; UTILITY; MULTIATTRIBUTE; VALUES; INDEX;
D O I
10.1016/j.jval.2018.05.010
中图分类号
F [经济];
学科分类号
02 ;
摘要
A standardized 5-level EuroQol 5-dimensional questionnaire (EQ-5D-5L) valuation protocol was first used in national studies in the period 2012 to 2013. A set of problems encountered in this initial wave of valuation studies led to the subsequent refinement of the valuation protocol. To clarify lessons learned and how the protocol was updated when moving from version 1.0 to the current version 2.1 and 2.0, this article will (1) present the challenges faced in EQ-5D-5L valuation since 2012 and how these were resolved and (2) describe in depth a set of new challenges that have become central in currently ongoing research on how EQ-5D-5L health states should be valued and modeled. Copyright (c) 2019, ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:23 / 30
页数:8
相关论文
共 50 条
  • [1] Valuation of the EQ-5D-5L in Taiwan
    Lin, Hsiang-Wen
    Li, Chia-Ing
    Lin, Fang-Ju
    Chang, Jen-Yu
    Gau, Churn-Shiouh
    Luo, Nan
    Pickard, A. Simon
    Goni, Juan M. Ramos
    Tang, Chao-Hsiun
    Hsu, Chien-Ning
    PLOS ONE, 2018, 13 (12):
  • [2] EQ-5D-5L valuation study for Portugal
    Ferreira, Pedro L.
    Antunes, Patricia
    Ferreira, Lara N.
    Pereira, Luis N.
    QUALITY OF LIFE RESEARCH, 2017, 26 (01) : 87 - 87
  • [3] The EQ-5D-5L valuation study in Korea
    Seon-Ha Kim
    Jeonghoon Ahn
    Minsu Ock
    Sangjin Shin
    Jooyeon Park
    Nan Luo
    Min-Woo Jo
    Quality of Life Research, 2016, 25 : 1845 - 1852
  • [4] EQ-5D-5L Valuation for the Malaysian Population
    Shafie, Asrul Akmal
    Thakumar, Annushiah Vasan
    Lim, Ching Jou
    Luo, Nan
    Rand-Hendriksen, Kim
    Yusof, Faridah Aryani Md
    PHARMACOECONOMICS, 2019, 37 (05) : 715 - 725
  • [5] EQ-5D-5L VALUATION STUDY IN TAIWAN
    Lin, H.
    Li, C.
    Lin, F.
    Chang, J.
    Gau, C.
    Luo, N.
    Pickard, A. S.
    Goni, Ramos J. M.
    Tang, C.
    Hsu, C.
    VALUE IN HEALTH, 2018, 21 : S91 - S91
  • [6] EQ-5D-5L Valuation for the Malaysian Population
    Asrul Akmal Shafie
    Annushiah Vasan Thakumar
    Ching Jou Lim
    Nan Luo
    Kim Rand-Hendriksen
    Faridah Aryani Md Yusof
    PharmacoEconomics, 2019, 37 : 715 - 725
  • [7] The EQ-5D-5L Valuation study in Thailand
    Pattanaphesaj, Juntana
    Thavorncharoensap, Montarat
    Ramos-Goni, Juan Manuel
    Tongsiri, Sirinart
    Ingsrisawang, Lily
    Teerawattananon, Yot
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2018, 18 (05) : 551 - 558
  • [8] The EQ-5D-5L Valuation Study in Egypt
    Al Shabasy, Sahar A.
    Abbassi, Maggie M.
    Finch, Aureliano Paolo
    Baines, Darrin
    Farid, Samar F.
    PHARMACOECONOMICS, 2022, 40 (04) : 433 - 447
  • [9] The EQ-5D-5L Valuation Study in Egypt
    Sahar Al Shabasy
    Maggie Abbassi
    Aureliano Finch
    Bram Roudijk
    Darrin Baines
    Samar Farid
    PharmacoEconomics, 2022, 40 : 433 - 447
  • [10] The EQ-5D-5L valuation study in Korea
    Kim, Seon-Ha
    Ahn, Jeonghoon
    Ock, Minsu
    Shin, Sangjin
    Park, Jooyeon
    Luo, Nan
    Jo, Min-Woo
    QUALITY OF LIFE RESEARCH, 2016, 25 (07) : 1845 - 1852